SEC - The United States Securities and Exchange Commission

02/07/2023 | Press release | Distributed by Public on 02/08/2023 08:34

Opinion/Adjudicatory Order 34-96831 (ZhongTai Biotechnology Pharmaceutical Group Co., Ltd.)